1University of South Dakota Sanford School of Medicine, Sioux Falls, SD [email protected]
2Arizona Liver Health, Chandler, AZ
Dr. Alkhouri reports having received research grants (paid to institution) from 89Bio, Akero, Better Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Corcept, DSM, Eli Lilly, Galectin, Genentech, Genfit, Gilead, Hepagene, Healio, Intercept, Inventiva, Ionis, Madrigal, Merck, NGM, Noom, NorthSea, Novo Nordisk, Perspectum, Pfizer, Poxel, Viking, and Zydus; having received lecture fees from AbbVie, Alexion, Echosens, Eisai, Exelixis, Gilead, Intercept, Perspectum, Salix, and Theratechnologies; and having received consulting fees from AbbVie/Allergan, Echosens, Fibronostics, Gilead, Intercept, Madrigal, Novo Nordisk, Perspectum, Pfizer, and Zydus. No other potential conflict of interest relevant to this letter was reported.
